Home » UPC decisions » Luxembourg Court of Appeal » Court of Appeal, December 19, 2025, Order concerning the need to adjudicate pursuant to R. 360 RoP, UPC-CoA-906/2025

Court of Appeal, December 19, 2025, Order concerning the need to adjudicate pursuant to R. 360 RoP, UPC-CoA-906/2025

3 min Reading time

Key takeaways

An appeal against a procedural order excluding evidence becomes moot if the main action is subsequently decided in the appellant’s favor, as no further advantage can be gained.

The Court of Appeal may admit evidence even if it was correctly excluded by the Court of First Instance, after considering all circumstances of the case. Evidence wrongfully rejected by the Court of First Instance shall be taken into account in the appeal, without the need for a separate appeal against that rejection.

Division

Court of Appeal

UPC number

UPC_CoA_906/2025

Type of proceedings

Procedural appeal

Parties

Appellant: Viatris Santé

Respondents: Merz Pharmaceuticals LLC, Merz Therapeutics GmbH, Merz Pharma France

Patent(s)

EP 2 377 536

Body of legislation / Rules

R. 220.2 RoP
R. 222.2 RoP
R. 333 RoP
R. 353 RoP
R. 360 RoP


Was the article helpful?


Categories


Tags

  • German and European Patent Attorney, UPC Representative, Senior Associate

  • Dr. Anna Giedke, Attorney-at-Law (Rechtsanwältin), UPC Representative, Partner at BARDEHLE PAGENBERG

    Attorney-at-Law (Rechtsanwältin), UPC Representative, Partner

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field